**Core Concept**
The management of a patient with a mural thrombus in the context of atrial fibrillation post-myocardial infarction involves anticoagulation to prevent thromboembolic events, while also considering the risk of bleeding. This requires a balance between the benefits of anticoagulation and the risks of bleeding, particularly in the setting of recent myocardial infarction.

**Why the Correct Answer is Right**
A mural thrombus forms in the left atrium as a result of atrial fibrillation, which increases the risk of thromboembolic events, including stroke. Anticoagulation with warfarin or a novel oral anticoagulant (NOAC) is recommended to prevent these events. However, in the setting of recent myocardial infarction, there is an increased risk of bleeding, particularly gastrointestinal bleeding. **Aspirin** is often used as an alternative to warfarin or NOACs in this scenario, as it has a lower risk of bleeding but still provides some degree of anticoagulation.

**Why Each Wrong Option is Incorrect**
**Option A:** Warfarin is a vitamin K antagonist that requires regular monitoring of INR levels. While it is effective for anticoagulation, it has a higher risk of bleeding compared to aspirin, making it a less ideal choice in this scenario.
**Option B:** NOACs are a class of anticoagulants that have a lower risk of bleeding compared to warfarin. However, in the setting of recent myocardial infarction, the risk of bleeding with NOACs is still a concern, and aspirin may be a more suitable alternative.
**Option C:** Antiplatelet therapy with clopidogrel is often used in the setting of recent myocardial infarction to prevent further ischemic events. However, it is not effective for preventing thromboembolic events in the setting of a mural thrombus.

**Clinical Pearl / High-Yield Fact**
Aspirin is often used as an alternative to warfarin or NOACs in patients with a mural thrombus post-myocardial infarction due to its lower risk of bleeding. This highlights the importance of weighing the benefits and risks of anticoagulation in each individual patient.

**Correct Answer: A. Aspirin**